Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

INSULIN GLARGINE\LIXISENATIDE for Diabetes mellitus: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 488 adverse event reports in the FDA FAERS database where INSULIN GLARGINE\LIXISENATIDE was used for Diabetes mellitus.

Most Reported Side Effects for INSULIN GLARGINE\LIXISENATIDE

Side Effect Reports % Deaths Hosp.
Blood glucose increased 419 13.8% 1 20
Product storage error 379 12.5% 0 7
Accidental exposure to product 258 8.5% 0 0
Off label use 205 6.8% 0 4
Visual impairment 136 4.5% 1 2
Inappropriate schedule of product administration 132 4.4% 0 5
Nausea 132 4.4% 1 20
Exposure via skin contact 125 4.1% 0 0
Drug ineffective 98 3.2% 0 6
Blood glucose decreased 94 3.1% 0 6
Device issue 85 2.8% 0 2
Injection site pain 75 2.5% 0 2
Hypoglycaemia 74 2.4% 1 18
Wrong technique in device usage process 74 2.4% 0 0
Device operational issue 72 2.4% 0 0

Other Indications for INSULIN GLARGINE\LIXISENATIDE

Type 2 diabetes mellitus (1,482) Product used for unknown indication (64) Type 1 diabetes mellitus (56) Blood glucose abnormal (34) Blood glucose increased (32) Blood glucose (9) Diabetes mellitus inadequate control (9) Hyperglycaemia (7)

Other Drugs Used for Diabetes mellitus

ROSIGLITAZONE (45,088) INSULIN GLARGINE (19,253) METFORMIN (17,371) INSULIN LISPRO (16,084) DULAGLUTIDE (7,557) INSULIN HUMAN (6,813) TIRZEPATIDE (5,209) SITAGLIPTIN (4,792) METFORMIN\ROSIGLITAZONE (4,438) EMPAGLIFLOZIN (4,267)

Related Pages

INSULIN GLARGINE\LIXISENATIDE Full Profile All Diabetes mellitus Drugs INSULIN GLARGINE\LIXISENATIDE Demographics INSULIN GLARGINE\LIXISENATIDE Timeline